Özlem Ünal

Dr. Özlem Ünal

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Clinical Biochemistry
Verified
Journal Article
Closed access
EKEngin Köse
Engin Köse
ÖÜÖzlem Ünal
Özlem Ünal
SBSelda Bulbul
Selda Bulbul
MGMehmet Gunduz
Mehmet Gunduz
JHJohannes Häberle
Johannes Häberle
NANur Arslan
Nur Arslan

4 June 2010 in Clinical Linguistics & Phonetics
Verified
Journal Article
Closed access
STSeyhun Topbaş
Seyhun Topbaş
ÖÜÖzlem Ünal
Özlem Ünal
A single-subject alternating treatment design in combination with a staggered multiple baseline model across subjects was implemented with two 6:0 year-old girls, monozygotic twins, who were referred to a university clinic for evaluation and treatment. The treatment programme was structured according to variants of minimal pair contrast treatment in which the target sounds and their oppositions were selected according to either minimal or maximal opposition (including major-class differences) contrast treatments to evaluate which of the sound selection strategy would result in better learning. Independent variables were the minimal and maximal opposition conditions; dependent variables were the target phonemes treated. Consistent with the literature, maximal opposition treatment resulted in significantly greater changes in the sound systems of the twins than minimal opposition treatment.

1 December 2016 in Ultrasound Quarterly
Verified
Journal Article
Closed access
ÖÜÖzlem Ünal
Özlem Ünal
NCNurdan Cay
Nurdan Cay
FYFatma Yulek
Fatma Yulek
ATAyse Guzin Taslipinar
Ayse Guzin Taslipinar
SBSelen Bozkurt
Selen Bozkurt
MGMehmet Gumus
Mehmet Gumus
Objective: To investigate the significance of ultrasound elastography for evaluating the optic nerve in patients with primary open angle glaucoma (POAG). Methods: This prospective, comparative case series included 40 eyes of 40 patients. Twenty eyes with POAG comprised the POAG group, and 20 eyes of 20 patients without glaucoma who admitted to general eye clinic for near vision glasses comprised the control group. All real-time sonographicelastographic examinations were performed by the same physician. The ratio of orbital fat to optic nerve head (ROFON) and lateral rectus to optic nerve head (RLRON) were determined. Statistical analyses were performed using Student t test, Kolmogorov-Smirnov test, and χ2 test. Results: The mean ages of the patients in the study and the control groups were 65.10 ± 7.88 years (range, 48–80 years), and 69.15 ± 7.92 years (range, 55–89 years), respectively (P = 0.113). Mean ROFONs were 1.85 and 6.42 (P < 0.05), and mean RLRONs were 0.65 and 1.07 (P < 0.05) in the control and POAG groups, respectively. Conclusions: Real-time elastography showed increased ROFON and RLRON in POAG patients. This can help to understand optic nerve head biomechanics and clarify glaucoma damage in early glaucoma cases.

12 March 2019 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
ÖÜÖzlem Ünal
Özlem Ünal
MCMehmet Erol Can
Mehmet Erol Can
AOAysenur Ozcan
Aysenur Ozcan
MOMeltem Ece Ozcan
Meltem Ece Ozcan
ŞEŞükran Erten
Şükran Erten
NCNurullah Cagil
Nurullah Cagil

30 December 2019 in Düzce Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
PDF file
ÖÜÖzlem Ünal
Özlem Ünal
ŞGŞule Güzel
Şule Güzel
SISinem Şi̇ği̇t İki̇z
Sinem Şi̇ği̇t İki̇z
AÖAyşenur ŞİRİN ÖZCAN
Ayşenur ŞİRİN ÖZCAN
Aim: To investigate the reliability of sonoelastography by comparing the Achilles tendon strain ratio obtained in healthy volunteers by different observers with different sonoelastography devices working on the same principle.Material and Methods: A total of 80 Achilles tendons in 40 volunteers without chronic disease were evaluated using Toshiba and Hitachi devices using real-time elastography principle. The Kager fat pad was selected for strain ratio measurement. Each tendon was evaluated with both devices twice by both observers. The intraobserver and interobserver agreement were examined by intraclass correlation coefficient (ICC) obtained by two-way mixed ANOVA model for absolute agreement and interpreted as Ko and Li (11) suggested.Results: Interobserver agreement in the first and second measurements of the Hitachi device and in the second measurements of the Toshiba device was found to be good (average ICC>0.75). The interobserver agreement in the first measurements made on the Toshiba device was found to be lower (average ICC=0.729, p0.90) for both device. The interobserver agreement for the Toshiba device was found lower than for the Hitachi device. Mean strain ratio was 2.96±1.07 for the Hitachi device and 3.54±1.03 for the Toshiba device. Measurements obtained from the Toshiba device were determined as significantly higher than those from the Hitachi device.Conclusion: There may be differences in strain rates depending on the compression application limits of the devices, in studies carried out using different devices. Therefore, intraobserver and interobserver agreement should be evaluated separately for each device.

25 February 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
ÖÜÖzlem Ünal
Özlem Ünal
SKServet Kocaöz
Servet Kocaöz
KOKamil Osma
Kamil Osma
FEFunda Eren
Funda Eren
Background: Asprosin is a fasting-induced adipokine involved in metabolic regulation and has recently been implicated in cancer biology. However, data regarding its diagnostic accuracy and clinicopathological associations in breast cancer remain limited. Methods: Serum asprosin levels were measured in patients with breast cancer and healthy controls using ELISA. Associations between serum asprosin levels and clinicopathological parameters were analyzed, and accuracy performance was evaluated using receiver operating characteristic (ROC) curve analysis. Results: Serum asprosin levels were significantly higher in the breast cancer group compared with controls (14.3 ng/mL vs. 11.0 ng/mL; p < 0.001). ROC curve analysis identified an optimal cutoff value of 12.2 ng/mL based on the Youden index, yielding a sensitivity of 66.4% and a specificity of 65.5%, indicating statistically significant yet moderate accuracy performance. A statistically significant difference in serum asprosin levels was observed according to HER2 status, smaller tumor size, and early-stage disease (p < 0.05). Serum asprosin levels tended to be higher in patients without axillary lymph node metastasis; however, this difference did not reach statistical significance (p = 0.050). No significant associations were observed with estrogen receptor positivity or the Ki-67 proliferation index. Serum asprosin levels were also correlated with body mass index and breast cancer presence (Spearman’s rho, p < 0.01). Conclusions: Serum asprosin levels are elevated in patients with breast cancer and demonstrate moderate accuracy performance. Increased levels observed in early-stage disease suggest that asprosin may reflect early tumor biological characteristics rather than overall tumor burden. Further large-scale and longitudinal studies are required to validate its clinical utility.